Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06009159 · ClinicalTrials.gov registry record · NA
Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patients
A NA study of Fibromyalgia, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06009159: Recruiting NA study of Fibromyalgia, sponsored by Massachusetts General Hospital.
NCT06009159 is a NA study of Fibromyalgia that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 60 participants, below the 178-participant average among 76 other Fibromyalgia trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06009159, a NA study of Fibromyalgia, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Fibromyalgia (FM) is a syndrome with clinical symptoms involving multiple systems. The efficacy of current treatments is inadequate, and more alternative modalities are needed for the management of FM patients. The parasympathetic vagus nerve innervates and integrates sensory, motor, and autonomic systems and has been suggested to play a role in pain modulation. The role of vagus nerve stimulation (VNS) as a treatment option for FM patients is yet to be investigated. The investigators propose to examine the hypothesis that vagus nerve stimulation could improve pain and related comorbid symptoms for FM patients.
Primary Outcome
Pain intensity, 0-10 score, with 0 means no pain and 10 means worst pain
Conditions Studied
Interventions
- DEVICE Transcutaneous Vagus Nerve Stimulation
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2026-10-31 |
| Phase | NA |
What NCT06009159 shows while recruiting
NCT06009159 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 178-participant average among 76 other Fibromyalgia trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous Vagus Nerve Stimulation is the first listed.
NCT06009159 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06009159 about?
NCT06009159 is a clinical study titled "Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patients". Fibromyalgia (FM) is a syndrome with clinical symptoms involving multiple systems. The efficacy of current treatments is inadequate, and more alternative modalities are needed for the management of FM patients. The parasympathetic vagus nerve innervates and integrates sensory, motor, and autonomic s...
What is the current status of trial NCT06009159?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-07-01. Estimated completion is 2026-10-31.
What conditions does trial NCT06009159 study?
This clinical trial studies the following conditions: Fibromyalgia.
What interventions are being tested in trial NCT06009159?
The interventions under investigation include: Transcutaneous Vagus Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT06009159?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06009159 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fibromyalgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06009159's enrollment target sits among peer trials
60 41st of 76 higher than 32 of 76 other Fibromyalgia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fibromyalgia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Auricular Neuromodulation in Veterans With Fibromyalgia
RECRUITING · NA
-
Effects of Breathing and Attention Training (BAT) on Pain Modulation
RECRUITING · NA
-
Neural Mechanisms of Light Driven Analgesia
RECRUITING · NA
-
Fibromyalgia Sleep A to ZZZ Study
RECRUITING · NA
-
Explosive Synchronization of Brain Network Activity in Chronic Pain
RECRUITING · NA
-
Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI